Detalhe da pesquisa
1.
Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilot.
Cancer
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662502
2.
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort.
Invest New Drugs
; 42(1): 127-135, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38270822
3.
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study.
Lancet Oncol
; 24(5): 496-508, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142372
4.
Patient-reported Adverse Events During Neoadjuvant Therapy in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501).
Ann Surg
; 278(4): 598-608, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334719
5.
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer.
Curr Treat Options Oncol
; 24(12): 1739-1757, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37966682
6.
Pancreatic cancer risk to siblings of probands in bilineal cancer settings.
Genet Med
; 24(5): 1008-1016, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35227607
7.
A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma.
Invest New Drugs
; 40(1): 134-141, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34463891
8.
Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignancies.
Invest New Drugs
; 40(1): 115-123, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34515877
9.
A feasibility study of virtual group therapy to improve quality of life of cancer caregivers.
J Psychosoc Oncol
; 40(6): 854-867, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34842060
10.
Considerations in the management of younger patients with colorectal cancer.
Clin Adv Hematol Oncol
; 19 Suppl 16(6): 1-20, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35289787
11.
Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma.
Oncologist
; 25(11): e1681-e1690, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32663355
12.
A Systematic Review and Network Meta-Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer.
Oncologist
; 24(9): 1174-1179, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31164455
13.
Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials.
Oncologist
; 24(1): 96-102, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413668
14.
Association between treatment facility volume, therapy types and overall survival in patients with intrahepatic cholangiocarcinoma.
HPB (Oxford)
; 21(3): 379-386, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30266490
15.
Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience.
Oncologist
; 23(9): 1083-1091, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29674439
16.
Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas.
BMC Cancer
; 17(1): 505, 2017 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28750659
17.
Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies.
Invest New Drugs
; 34(1): 96-103, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26581401
18.
Treatment selection for younger patients with metastatic colorectal cancer.
Clin Adv Hematol Oncol
; 19 Suppl 16(6): 11-15, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35289791
19.
Cases in the management of metastatic colorectal cancer: rechallenge with chemotherapy after regorafenib in a patient with RAS/BRAF wild-type disease.
Clin Adv Hematol Oncol
; 19 Suppl 12(4): 1-8, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35290294
20.
Considerations in the management of younger patients With colorectal cancer: Q&A.
Clin Adv Hematol Oncol
; 19 Suppl 16(6): 15-17, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35289792